Motilium works primarily by blocking peripheral dopamine receptors to speed gastric emptying, whereas many other anti-nausea agents (e.g., ondansetron) target serotonin receptors in the central nervous system. This distinct mechanism makes domperidone especially useful for nausea linked to delayed gastric motility.
Domperidone is not indicated for gastro-oesophageal reflux disease (GERD). Although it may reduce reflux episodes by improving stomach emptying, evidence is insufficient for routine use in GERD management.
Yes, Motilium is a prescription-only medicine in the UK. Carry a copy of the prescription and the original packaging when traveling internationally to satisfy customs or airline requirements.
Patients often notice a reduction in nausea within 30 minutes to a few hours after the first dose, correlating with the drug’s rapid absorption and onset of action.
No specific food restrictions exist. The tablet may be taken with or without food; however, taking it shortly before a meal can optimise its pro-kinetic effect.
Domperidone does not interfere with hormonal contraceptives. Nevertheless, pregnant or breastfeeding individuals should discuss any medication use with their clinician.
Limiting the dose reduces the risk of cardiac side effects, particularly QT interval prolongation, which has been linked to higher daily doses and co-administration with certain other drugs.
A rapid or irregular heartbeat may signal a serious cardiac reaction. Seek immediate medical attention, and inform the healthcare provider that you are taking domperidone.
In the UK, domperidone is primarily marketed as 10 mg tablets (Motilium). Liquid or oral suspension forms are not commonly marketed for this indication.
Both are pro-kinetic agents, but domperidone has limited central nervous system penetration, resulting in a lower incidence of extrapyramidal side effects compared with metoclopramide. Choice between them depends on patient tolerance, cardiac risk, and clinician preference.
Motilium contains the active ingredient domperidone, a dopaminergic antagonist used to promote normal gastrointestinal (GI) motility. It is supplied as a 10 mg pill and is classified under Digestive Health medications. In the United Kingdom, Motilium is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Domperidone blocks dopamine D₂ receptors located in the gut wall and the chemoreceptor trigger zone of the brain. By inhibiting dopamine’s inhibitory effect on gastric smooth muscle, the drug enhances upper-GI motility, accelerates gastric emptying, and reduces the feeling of nausea. Because it does not readily cross the blood-brain barrier, central dopaminergic side effects are limited. The therapeutic effect typically begins within a few hours after the first dose, with peak plasma concentrations occurring about 30 minutes post-ingestion. The drug’s elimination half-life is roughly 7-9 hours, largely through hepatic metabolism via CYP3A4.
Motilium is approved in the UK for the following indications:
These indications reflect its ability to improve the coordinated movement of the stomach and upper intestine.
Small clinical studies have examined domperidone for increasing lactational milk volume in mothers with low supply. While the medication is not licensed for this purpose in the UK, the limited evidence suggests a modest rise in milk output when used at standard doses. Off-label use requires close supervision by a qualified healthcare professional, and the potential cardiac risks must be weighed against the expected benefit.
Disclaimer: Off-label use of domperidone must be prescribed and monitored by a physician. The decision should be individualized based on clinical assessment and patient risk factors.
These effects are generally transient and do not require medical intervention unless they persist.
Patients experiencing palpitations, fainting, or irregular heartbeats should seek urgent medical attention.
Safety Note: Always disclose all prescribed medicines, over-the-counter products, herbal supplements, and vitamins to the prescribing clinician before starting Motilium.
Missed dose: If a dose is forgotten, it may be taken as soon as remembered provided there is at least a 4-hour gap before the next scheduled dose. Do not double the dose to catch up.
Overdose: Symptoms may include severe dizziness, fainting, rapid heart rate, or cardiac arrhythmias. Immediate medical evaluation is required; treatment is mainly supportive, with cardiac monitoring and, if indicated, administration of sodium bicarbonate for severe QT prolongation.
Discontinuation: Sudden cessation is usually well tolerated. In patients using high-dose or prolonged therapy, a gradual taper may be considered to monitor for rebound nausea.
This article provides educational information about Motilium (domperidone) and is not a substitute for professional medical advice. Treatment decisions, including the use of any medication for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
